MATTHEW DAVEY: Open Payments
NPI 1881325165 · ERLANGER, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$525 in 19 payments from 6 companies in 2025. Trend: 2023 $578 · 2024 $395 · 2025 $525
Food & beverage: $525
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $303 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $76 |
| Gilead Sciences, Inc. | 2 | $56 |
| Indivior Inc. | 2 | $48 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| Braeburn Inc. | 1 | $16 |
Products named: VRAYLAR, CAPLYTA, SUBLOCADE, FANAPT, MAVYRET, BRIXADI.
Industry payments across KY — which companies pay providers there.
